Mergers and acquisitions on the pharmaceutical market: global experience and Russian specifics
Aleksandr Evstratov, Irina Ezangina, Maria Shendo, Tatiana Luneva
Available Online June 2019.
- https://doi.org/10.2991/cssdre-19.2019.12How to use a DOI?
- global pharmaceutical market, Russian pharmaceutical market, merger and acquistion deals, merger and acuisition deals motives
- Formation and development of pharmaceutical market inevitably leads to situations that act as catalysts for structural market changes. These situations include mergers and acquisitions increasing market concentration and having positive or negative influence on all market participants. This is why such processes undoubtedly have the potential for research. Studying methods for assessing efficiency of merger and acquisition processes remains a relevant issue while implementation of existing approaches to practical business activities requires theoretical reasoning. The authors consider the analysis of M&A deals to be relevant because these processes result in change of balance between market participants, transformation of pricing and marketing strategies. Due to social significance of pharmaceutical market, its changes affect availability of medicines for consumers. This article studies methods for assessing efficiency of merger and acquisition deals and for assessing company value.
- Open Access
- This is an open access article distributed under the CC BY-NC license.
Cite this article
TY - CONF AU - Aleksandr Evstratov AU - Irina Ezangina AU - Maria Shendo AU - Tatiana Luneva PY - 2019/06 DA - 2019/06 TI - Mergers and acquisitions on the pharmaceutical market: global experience and Russian specifics BT - Volgograd State University International Scientific Conference "Competitive, Sustainable and Safe Development of the Regional Economy" (CSSDRE 2019) PB - Atlantis Press SP - 59 EP - 63 SN - 2352-5428 UR - https://doi.org/10.2991/cssdre-19.2019.12 DO - https://doi.org/10.2991/cssdre-19.2019.12 ID - Evstratov2019/06 ER -